Suppr超能文献

心脏病患者冠状动脉小动脉对腺苷的血管舒张机制。

Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease.

作者信息

Sato Atsushi, Terata Ken, Miura Hiroto, Toyama Kazuyoshi, Loberiza Fausto R, Hatoum Ossama A, Saito Takashi, Sakuma Ichiro, Gutterman David D

机构信息

Dept. of Medicine, Cardiovascular Center, and Veterans Administration Medical Center, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.

出版信息

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1633-40. doi: 10.1152/ajpheart.00575.2004.

Abstract

Adenosine is a key myocardial metabolite that elicits coronary vasodilation in a variety of pathophysiological conditions. We examined the mechanism of adenosine-induced vasodilation in coronary arterioles from patients with heart disease. Human coronary arterioles (HCAs) were dissected from pieces of the atrial appendage obtained at the time of cardiac surgery and cannulated for the measurement of internal diameter with videomicroscopy. Adenosine-induced vasodilation was not inhibited by endothelial denudation, but A(2) receptor antagonism with 3,7-dimethyl-1-propargylxanthine and adenylate cyclase (AC) inhibition with SQ22536 significantly attenuated the dilation. In contrast, A(1) receptor antagonism with 8-cyclopentyl-1,3-dipropylxanthine significantly augmented the sensitivity to adenosine. Moreover, dilation to A(2a) receptor activation with 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido-adenosine hydrochloride was reduced by the A(1) receptor agonist (2S)-N(6)-(2-endo-norbornyl)adenosine. The nonspecific calcium-activated potassium (K(Ca)) channel blocker tetrabutylammonium attenuated adenosine-induced dilation, as did the intermediate-conductance K(Ca) blocker clotrimazole. Neither the large-conductance K(Ca) blocker iberiotoxin nor small-conductance K(Ca) blocker apamin altered the dilation. In conclusion, adenosine endothelium independently dilates HCAs from patients with heart disease through a receptor-mediated mechanism that involves the activation of intermediate-conductance K(Ca) channels via an AC signaling pathway. The roles of A(1) and A(2) receptor subtypes are opposing, with the former being inhibitory to AC-mediated dilator actions of the latter. These observations identify unique fundamental physiological characteristics of the human coronary circulation and may help to target the use of novel adenosine analogs for vasodilation in perfusion imaging or suggest new strategies for myocardial preconditioning.

摘要

腺苷是一种关键的心肌代谢产物,在多种病理生理条件下可引起冠状动脉扩张。我们研究了心脏病患者冠状动脉小动脉中腺苷诱导血管扩张的机制。从心脏手术时获取的心房附件组织中分离出人类冠状动脉小动脉(HCA),并插管,通过视频显微镜测量内径。腺苷诱导的血管扩张不受内皮剥脱的抑制,但用3,7-二甲基-1-丙炔基黄嘌呤进行A(2)受体拮抗以及用SQ22536抑制腺苷酸环化酶(AC)可显著减弱这种扩张。相反,用8-环戊基-1,3-二丙基黄嘌呤进行A(1)受体拮抗可显著增强对腺苷的敏感性。此外,A(1)受体激动剂(2S)-N(6)-(2-内-降冰片基)腺苷可降低用2-对-(2-羧乙基)苯乙氨基-5'-N-乙基羧酰胺基-腺苷盐酸盐激活A(2a)受体所引起的扩张。非特异性钙激活钾(K(Ca))通道阻滞剂四丁基铵可减弱腺苷诱导的扩张,中电导K(Ca)通道阻滞剂克霉唑也有同样作用。大电导K(Ca)通道阻滞剂iberiotoxin和小电导K(Ca)通道阻滞剂蜂毒明肽均未改变这种扩张。总之,腺苷可通过一种受体介导机制使心脏病患者的HCA内皮独立扩张,该机制涉及通过AC信号通路激活中电导K(Ca)通道。A(1)和A(2)受体亚型的作用相反,前者对后者的AC介导的扩张作用起抑制作用。这些观察结果确定了人类冠状动脉循环独特的基本生理特征,可能有助于在灌注成像中靶向使用新型腺苷类似物进行血管扩张,或为心肌预处理提出新策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验